Standard BioTools Inc.

NASDAQ: LAB · Real-Time Price · USD
1.20
-0.02 (-1.64%)
At close: Aug 15, 2025, 9:56 AM

Standard BioTools Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
21.76M 40.8M 46.72M 44.97M 37.2M 45.54M 28.19M 25.37M 27.67M 25.12M 27.02M 25.65M 18.78M 26.5M 38.27M 28.5M 31.02M 32.79M
Cost of Revenue
-747K 21.05M 24.81M 21.71M 22.3M 21.35M 14.83M 14.21M 14.06M 12.99M 15.85M 16.43M 14.35M 14.27M 18.02M 14.84M 14.6M 13.75M
Gross Profit
1.94M 19.74M 21.91M 23.26M 14.91M 24.19M 13.36M 11.15M 13.6M 12.12M 11.17M 9.22M 4.43M 12.24M 20.24M 13.67M 16.42M 19.04M
Operating Income
-19.7M -32.97M -32.82M -31.72M -50.52M -60.18M -14.91M -21.17M -17.45M -16.59M -21.11M -29.03M -38.56M -27.5M -11.26M -19.61M -17.27M -19.32M
Interest Income
2.46M 2.92M 6.64M 3.94M 4.44M 5.17M n/a 1.22M 1.13M 1.12M n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-15.59M -26.18M -33.8M -26.82M -45.66M -32.03M -19.94M -20.95M -16.74M -16.58M -20.77M -30.14M -65.15M -76.86M -10.24M -15.27M -17.66M -20.49M
Net Income
-33.46M -26.03M -34.07M -26.94M -45.72M -32.16M -19.78M -21M -17.04M -16.84M -20.84M -29.43M -63.54M -76.29M -9.43M -13.84M -17.14M -18.82M
Selling & General & Admin
19.22M 38.71M 37.59M 34.4M 37.67M 46.94M 21.35M 22.29M 22.6M 22.31M 23.9M 29.6M 30.38M 30.88M 22.96M 24.07M 24.25M 27.61M
Research & Development
334K 11.33M 14.05M 13.16M 19.22M 15.98M 6.91M 6.37M 6.18M 6.41M 8.38M 8.65M 12.61M 8.87M 8.54M 9.21M 9.44M 10.75M
Other Expenses
n/a 2.68M 3.08M 7.42M 29.98M n/a n/a 3.66M n/a n/a n/a -63K n/a 118K n/a n/a n/a -285K
Operating Expenses
19.56M 52.71M 54.72M 54.98M 86.87M 62.92M 28.26M 32.33M 28.78M 28.72M 32.28M 38.25M 42.99M 39.74M 31.5M 33.28M 33.69M 38.36M
Interest Expense
9K 2K 3.32M n/a n/a 1.03M 1.1M 1.22M 1.13M 1.12M 1.19M 1.05M 1.06M 1.03M 1.07M 968K 896K 887K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
45.46M 73.77M 79.53M 76.69M 87.72M 105.72M 49.57M 46.54M 42.85M 41.71M 48.13M 54.67M 57.34M 54.01M 49.52M 48.12M 48.29M 52.11M
Income Tax Expense
-609K -151K 272K 118K 55K 128K -162K 50K 301K 263K 70K -713K -1.61M -574K -814K -1.42M -517K -1.67M
Shares Outstanding (Basic)
379.37M 378.23M 374.54M 371.54M 372.33M 294.13M 79.73M 79.15M 78.67M 79.08M 79.43M 78.9M 77.49M 77.03M 76.65M 76.3M 74.53M 74.71M
Shares Outstanding (Diluted)
379.37M 378.23M 374.54M 371.54M 372.33M 294.13M 79.73M 79.15M 78.67M 79.08M 79.43M 78.9M 77.82M 77.03M 76.65M 76.3M 75.45M 74.71M
EPS (Basic)
-0.09 -0.07 -0.09 -0.07 -0.12 -0.27 -0.25 -0.27 -0.22 -0.21 -0.26 -0.37 -0.82 -0.99 -0.12 -0.18 -0.23 -0.25
EPS (Diluted)
-0.09 -0.07 -0.09 -0.07 -0.12 -0.27 -0.25 -0.27 -0.22 -0.21 -0.26 -0.37 -0.82 -0.99 -0.12 -0.18 -0.23 -0.25
EBITDA
-16.27M -22.01M -29.85M -23.23M -41.81M -26.84M -14.93M -15.74M -11.98M -11.8M -15.97M -25.49M -60.26M -71.86M -5.17M -10.31M -12.75M -15.69M
EBIT
-18.27M -26.18M -33.8M -26.66M -35.8M -32.55M -18.84M -19.72M -15.18M -15.44M -19.59M -29.09M -64.09M -75.83M -9.17M -14.3M -16.76M -19.61M
Depreciation & Amortization
2M 4.17M 3.95M 3.43M 3.86M 5.19M 3.91M 3.99M 3.63M 3.66M 3.62M 3.6M 3.83M 3.97M 4M 3.99M 4.01M 4.07M